Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerarda J M Herder

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Thoracic Cancer|October 19, 2020
Genetic variants as predictors of toxicity and response in patients with non-small cell lung cancer undergoing first-line platinum-based chemotherapy: Design of the multicenter PGxLUNG studyCorine de Jong, Gerarda J M Herder, Vera H M Deneer
Cancers|November 26, 2022
Performance and Prospects of [<sup>68</sup>Ga]Ga-FAPI PET/CT Scans in Lung CancerPaula E Borgonje, Louise M Andrews, Gerarda J M Herder, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|October 31, 2014
Different cutoff values for thyroid transcription factor-1 antibodies in the diagnosis of lung adenocarcinomaAlexander J J Smits, Aryan Vink, Gerda Tolenaars, et al.
Cardiovascular and Interventional Radiology|December 8, 2011
Pulmonary masses: initial results of cone-beam CT guidance with needle planning software for percutaneous lung biopsySicco J Braak, Gerarda J M Herder, Johannes P M van Heesewijk, et al.
Thoracic Cancer|May 9, 2020
Association between serum biomarkers CEA and LDH and response in advanced non-small cell lung cancer patients treated with platinum-based chemotherapyCorine de Jong, Vera H M Deneer, Johannes C Kelder, et al.
The Journal of Molecular Diagnostics : JMD|April 7, 2018
Added Value of 50-Gene Panel Sequencing to Distinguish Multiple Primary Lung Cancers from Pulmonary Metastases: A Systematic InvestigationPaul Roepman, Alexandra Ten Heuvel, Karen C Scheidel, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 22, 2013
Health-related quality of life and utility in patients with advanced non-small-cell lung cancer: a prospective cross-sectional patient survey in a real-world settingChristos Chouaid, Jason Agulnik, Erdem Goker, et al.
Plos One|May 30, 2013
Pemetrexed induced thymidylate synthase inhibition in non-small cell lung cancer patients: a pilot study with 3'-deoxy-3'-[¹⁸F]fluorothymidine positron emission tomographyVirginie Frings, Astrid A M van der Veldt, Ronald Boellaard, et al.
Plos One|January 7, 2022
Association of genetic variations in ACE2, TIRAP and factor X with outcomes in COVID-19Marissa J M Traets, Roel H T Nijhuis, Servaas A Morré, et al.
Genes|January 21, 2023
Association between Genetic Variants and Peripheral Neuropathy in Patients with NSCLC Treated with First-Line Platinum-Based TherapyCorine de Jong, Gerarda J M Herder, Simone W A van Haarlem, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Thoracic Cancer|October 19, 2020
Genetic variants as predictors of toxicity and response in patients with non-small cell lung cancer undergoing first-line platinum-based chemotherapy: Design of the multicenter PGxLUNG studyCorine de Jong, Gerarda J M Herder, Vera H M Deneer
Cancers|November 26, 2022
Performance and Prospects of [<sup>68</sup>Ga]Ga-FAPI PET/CT Scans in Lung CancerPaula E Borgonje, Louise M Andrews, Gerarda J M Herder, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|October 31, 2014
Different cutoff values for thyroid transcription factor-1 antibodies in the diagnosis of lung adenocarcinomaAlexander J J Smits, Aryan Vink, Gerda Tolenaars, et al.
Cardiovascular and Interventional Radiology|December 8, 2011
Pulmonary masses: initial results of cone-beam CT guidance with needle planning software for percutaneous lung biopsySicco J Braak, Gerarda J M Herder, Johannes P M van Heesewijk, et al.
Thoracic Cancer|May 9, 2020
Association between serum biomarkers CEA and LDH and response in advanced non-small cell lung cancer patients treated with platinum-based chemotherapyCorine de Jong, Vera H M Deneer, Johannes C Kelder, et al.
The Journal of Molecular Diagnostics : JMD|April 7, 2018
Added Value of 50-Gene Panel Sequencing to Distinguish Multiple Primary Lung Cancers from Pulmonary Metastases: A Systematic InvestigationPaul Roepman, Alexandra Ten Heuvel, Karen C Scheidel, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 22, 2013
Health-related quality of life and utility in patients with advanced non-small-cell lung cancer: a prospective cross-sectional patient survey in a real-world settingChristos Chouaid, Jason Agulnik, Erdem Goker, et al.
Plos One|May 30, 2013
Pemetrexed induced thymidylate synthase inhibition in non-small cell lung cancer patients: a pilot study with 3'-deoxy-3'-[¹⁸F]fluorothymidine positron emission tomographyVirginie Frings, Astrid A M van der Veldt, Ronald Boellaard, et al.
Plos One|January 7, 2022
Association of genetic variations in ACE2, TIRAP and factor X with outcomes in COVID-19Marissa J M Traets, Roel H T Nijhuis, Servaas A Morré, et al.
Genes|January 21, 2023
Association between Genetic Variants and Peripheral Neuropathy in Patients with NSCLC Treated with First-Line Platinum-Based TherapyCorine de Jong, Gerarda J M Herder, Simone W A van Haarlem, et al.
Pageof 3